ReviewGastro hep advances2025

Comparison Between Adalimumab and Infliximab in Perianal Crohn's Disease: A Systematic Review and Meta-Analysis.

Tarek Aboursheid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.